Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;96(1):97-102.
doi: 10.1007/s11060-009-0056-5. Epub 2009 Dec 3.

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

Tom Mikkelsen  1 , Nina A Paleologos, Paula D Robinson, Mario Ammirati, David W Andrews, Anthony L Asher, Stuart H Burri, Charles S Cobbs, Laurie E Gaspar, Douglas Kondziolka, Mark E Linskey, Jay S Loeffler, Michael McDermott, Minesh P Mehta, Jeffrey J Olson, Roy A Patchell, Timothy C Ryken, Steven N Kalkanis
Affiliations

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

Tom Mikkelsen et al. J Neurooncol. 2010 Jan.

Abstract

Question: Do prophylactic anticonvulsants decrease the risk of seizure in patients with metastatic brain tumors compared with no treatment?

Target population: These recommendations apply to adults with solid brain metastases who have not experienced a seizure due to their metastatic brain disease.

Recommendation: Level 3 For adults with brain metastases who have not experienced a seizure due to their metastatic brain disease, routine prophylactic use of anticonvulsants is not recommended. Only a single underpowered randomized controlled trial (RCT), which did not detect a difference in seizure occurrence, provides evidence for decision-making purposes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow of studies to final number of eligible studies
See this image and copyright information in PMC

References

    1. Perry J, Zinman L, Chambers A, Spithoff K, Lloyd N, Laperriere N. The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review. Curr Oncol. 2006;13(6):222–229. - PMC - PubMed
    1. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):1886–1893. - PubMed
    1. Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL (2009) Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol. doi:10.1007/s11060-009-0059-2 - PMC - PubMed
    1. Centre for Evidence-Based Physiotherapy (2009) Physiotherapy Evidence Database (PEDro). http://www.pedro.org.au/. Last Accessed in Jan 2009
    1. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–721. - PubMed

Publication types

MeSH terms